Literature DB >> 32305041

Aging-induced IL27Ra signaling impairs hematopoietic stem cells.

Hanqing He1, Panglian Xu1,2, Xiaofei Zhang1, Min Liao1, Qiongye Dong3, Tingting Cong1, Baixue Tang1, Xiuxiu Yang1, Maoqing Ye4, Yingjun Chang5, Weihua Liu6, Xiaowo Wang3, Zhenyu Ju7,8, Jianwei Wang1,9.   

Abstract

Hematopoietic stem cell (HSC) aging correlates with an increasing risk of myeloproliferative disease and immunosenescence. In this study, we show that aging-related inflammation promotes HSC aging through tumor necrosis factor-α (TNF-α)→ERKETS1interleukin27Ra (IL27Ra) pathway. TNF-α, a well-known biomarker of inflammation, increases during aging and induces the expression of IL27Ra on HSCs via ERK-ETS1 signaling. Deletion of IL27Ra rescues the functional decline and myeloid bias of HSCs and also reverses the inhibitory effect of TNF-α on HSCs. Aged IL27Ra-/- mice had a reduced proportion of myeloid-biased HSCs and did not display the biased myeloid differentiation that occurs in aged wild-type mice. IL27Ra+ HSCs exhibit impaired reconstitution capacity and myeloid-bias compared with IL27Ra- HSCs and serve as a myeloid-recovery pool upon inflammatory insult. Inflammation-related genes were enriched in IL27Ra+ HSCs and this enrichment increases with aging. Our study demonstrates that age-induced IL27Ra signaling impairs HSCs and raises the possibility that interfering with IL27Ra signaling can counter the physiologically deleterious effect of aging on hematopoietic capacity.
© 2020 by The American Society of Hematology.

Entities:  

Year:  2020        PMID: 32305041     DOI: 10.1182/blood.2019003910

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Aging, inflammation, and HSC.

Authors:  James DeGregori
Journal:  Blood       Date:  2020-07-09       Impact factor: 22.113

Review 2.  Human immune diversity: from evolution to modernity.

Authors:  Adrian Liston; Stephanie Humblet-Baron; Darragh Duffy; An Goris
Journal:  Nat Immunol       Date:  2021-11-18       Impact factor: 25.606

Review 3.  Ageing and rejuvenation of tissue stem cells and their niches.

Authors:  Anne Brunet; Margaret A Goodell; Thomas A Rando
Journal:  Nat Rev Mol Cell Biol       Date:  2022-07-20       Impact factor: 113.915

Review 4.  A feedback loop: Interactions between Inflammatory Signals and Clonal Hematopoiesis in Cardiovascular Disease.

Authors:  Jiashan Li; Chao Wang; Jiaru Liu; Ying Yu; Yuee Liu; Qi Peng; Huihui Liu; Xiuru Guan
Journal:  Mol Biol Rep       Date:  2021-05-13       Impact factor: 2.316

5.  Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38+ macrophages and NAD+ decline.

Authors:  Elena Ciaglia; Valentina Lopardo; Francesco Montella; Albino Carrizzo; Paola Di Pietro; Marco Malavolta; Robertina Giacconi; Fiorenza Orlando; Monica Cattaneo; Paolo Madeddu; Carmine Vecchione; Annibale Alessandro Puca
Journal:  Cell Death Dis       Date:  2022-01-27       Impact factor: 8.469

6.  Microbiota Signals Suppress B Lymphopoiesis With Aging in Mice.

Authors:  Joseph R Krambs; Darlene A Monlish; Feng Gao; Laura G Schuettpelz; Daniel C Link
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

Review 7.  Mitochondrial Contributions to Hematopoietic Stem Cell Aging.

Authors:  Claudia Morganti; Keisuke Ito
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

Review 8.  Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?

Authors:  Hal E Broxmeyer; Yan Liu; Reuben Kapur; Christie M Orschell; Arafat Aljoufi; James P Ropa; Thao Trinh; Sarah Burns; Maegan L Capitano
Journal:  Stem Cell Rev Rep       Date:  2020-11-03       Impact factor: 5.739

9.  Autophagy-Sirt3 axis decelerates hematopoietic aging.

Authors:  Yixuan Fang; Ni An; Lingjiang Zhu; Yue Gu; Jiawei Qian; Gaoyue Jiang; Ruijin Zhao; Wen Wei; Li Xu; Gaochuan Zhang; Xingyun Yao; Na Yuan; Suping Zhang; Yun Zhao; Jianrong Wang
Journal:  Aging Cell       Date:  2020-09-20       Impact factor: 9.304

10.  Thymopentin treatment of murine premature ovarian failure via attenuation of immune cell activity and promotion of the BMP4/Smad9 signalling pathway.

Authors:  Xueqin Zhu; Jianjun Liu; Hao Pan; Zixiang Geng; William Huang; Te Liu; Bimeng Zhang
Journal:  Int J Med Sci       Date:  2021-08-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.